首页 > 最新文献

Dermatologica Sinica最新文献

英文 中文
Use of cyclosporine in the treatment of patients with possible neurogenic rosacea presenting as persistent facial edema with burning sensation: A case series 应用环孢素治疗以持续面部水肿伴烧灼感为表现的可能神经源性酒渣鼻患者:一个病例系列
4区 医学 Q3 Medicine Pub Date : 2023-11-10 DOI: 10.4103/ds.ds-d-23-00041
I-Heng Chiu, Tsen-Fang Tsai
{"title":"Use of cyclosporine in the treatment of patients with possible neurogenic rosacea presenting as persistent facial edema with burning sensation: A case series","authors":"I-Heng Chiu, Tsen-Fang Tsai","doi":"10.4103/ds.ds-d-23-00041","DOIUrl":"https://doi.org/10.4103/ds.ds-d-23-00041","url":null,"abstract":"","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135186557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of alprostadil in chilblain lupus erythematosus 前列地尔治疗冻疮红斑狼疮疗效观察
4区 医学 Q3 Medicine Pub Date : 2023-11-10 DOI: 10.4103/ds.ds-d-23-00065
Wei-En Wang, Chung-Hsing Chang
Dear Editor, A 56-year-old woman presented with chronic pain in her digits. She had worked in the seafood frozen-packaging line of a food factory for many years. Physical examination revealed ulcerations on the pulps and knuckles of her digits, with hyperkeratosis and fissures [Figure 1a-d]. No similar lesions on toes were found. The lesions were worsened by exposure to a cold environment. Raynaud’s phenomenon and sclerodactyly were not observed. In addition, a patch of cicatricial alopecia was observed on the vertex of the scalp [Figure 1e]. Discoid lupus erythematosus was confirmed by skin biopsy.Figure 1: (a-d) Erythematous plaques with fissures and ulceration on the fingers and pulps of the digits. (e) A patch of cicatricial alopecia on the vertex of the scalp. (f and g) Bilateral hand magnetic resonance angiography showed patent distal radial arteries, ulnar to interdigital arteries, and postcontrast enhancement of soft tissue swelling over the 1st to 5th digits.Blood tests revealed high titers of anti-Ro/SSA antibodies (50.1 EliA U/mL) and low C4 levels (18.2 mg/dL). However, she tested negative for antinuclear antibodies (ANA), anticardiolipin antibodies, anti-Scl-70 antibodies, and anti-double-stranded DNA antibodies. The cryoglobulin and cold agglutinin tests were negative. A diagnosis of systemic lupus erythematosus (SLE) was not fulfilled. Bilateral hand magnetic resonance angiography showed patent distal radial arteries, ulnar to interdigital arteries, and postcontrast enhancement of soft-tissue swelling over the 1st to 5th digits [Figure 1f and g]. Based on her clinical symptoms and laboratory results, she was diagnosed with chilblain lupus erythematosus (CHLE). The proposed CHLE diagnostic criteria have not yet been validated, although the Mayo Clinic diagnostic criteria proposed by Su et al. include clinical presentation, laboratory findings, and histopathology.[1] She was treated with oral pentoxifylline and nifedipine for 5 months; however, only mild improvement was seen. We further administrated a 10-day regimen of intravenous alprostadil at a dose of 60 µg/day. Significant improvement in the digital ulcers was observed within 2 weeks [Figure 2a]. Laser Doppler flowmetry revealed increased microvascular perfusion in the digits of the left hand at 30°C and 44°C during the 8-week follow-up [Figure 2b].Figure 2: (a) The digital ulcers showed significant improvement within 2 weeks (left hand). (b) Laser Doppler flowmetry revealed an increase in microvascular perfusion in the middle digit of the left hand both at 30°C and 44°C after alprostadil treatment during an 8-week follow-up.CHLE is a rare form of cutaneous lupus erythematosus; based on previous studies, it coexists with SLE in 33%–88% of patients.[2,3] Moreover, SLE developed in these patients before or after the onset of CHLE.[2,3] CHLE lesions initially present as violaceous-erythematous papules and plaques on the toes, fingers, or face, and they worsen during exposure to co
亲爱的编辑:一位56岁的女性,因手指慢性疼痛而就诊。她曾在一家食品厂的海鲜冷冻包装生产线工作多年。体格检查显示其指髓和指关节溃疡,角化过度和裂缝[图1a-d]。足趾未见类似病变。暴露在寒冷的环境中会使病变恶化。未观察到雷诺现象和指关节硬化。此外,在头皮顶点处观察到一块瘢痕性脱发[图1e]。皮肤活检证实为盘状红斑狼疮。图1:(a-d)手指和指髓的红斑斑块伴裂隙和溃疡。(e)头皮顶点的一块瘢痕性脱发。(f和g)双侧手磁共振血管造影显示桡动脉远端通畅,尺侧至指间动脉通畅,1 - 5趾软组织肿胀增强。血液检查显示抗ro /SSA抗体高滴度(50.1 EliA U/mL)和低C4水平(18.2 mg/dL)。然而,她的抗核抗体(ANA)、抗心磷脂抗体、抗scl -70抗体和抗双链DNA抗体检测均为阴性。冷球蛋白和冷凝集素试验均为阴性。诊断为系统性红斑狼疮(SLE)不满足。双侧手磁共振血管造影显示桡动脉远端通畅,尺侧至指间动脉通畅,1 - 5趾软组织肿胀增强[图1f和g]。根据她的临床症状和实验室结果,诊断为冻疮红斑狼疮(CHLE)。虽然Su等人提出的梅奥诊所诊断标准包括临床表现、实验室结果和组织病理学,但建议的CHLE诊断标准尚未得到验证。[1]口服己酮茶碱、硝苯地平5个月;然而,只看到了轻微的改善。我们进一步以60µg/天的剂量静脉注射前列地尔,为期10天。2周内观察到手指溃疡的显著改善[图2a]。激光多普勒血流仪显示,在8周的随访中,在30°C和44°C时,左手手指微血管灌注增加[图2b]。图2:(a)手指溃疡在2周内明显改善(左手)。(b)激光多普勒血流测量显示,在8周的随访中,前列地尔治疗后,左手中指在30°C和44°C时微血管灌注增加。CHLE是一种罕见的皮肤红斑狼疮;根据以往的研究,33%-88%的患者与SLE共存。[2,3]此外,这些患者在CHLE发病之前或之后发生SLE。[2,3] CHLE病变最初表现为脚趾、手指或面部的紫色红斑丘疹和斑块,并在暴露于寒冷刺激或温度降低时恶化。随着CHLE病变的进展,可能会出现角化过度、溃疡和色素沉着。CHLE的抗体谱是非特异性的[4]。一项涉及30例CHLE患者的回顾性研究显示,80%的CHLE患者ANA阳性,50%的CHLE患者抗ssa阳性[3]。CHLE的治疗尚未标准化,尽管防寒是其管理的一个组成部分。目前的治疗方案包括局部或全身皮质类固醇、局部钙调磷酸酶抑制剂、抗疟药或免疫调节剂,如霉酚酸酯,这取决于疾病的严重程度。此外,据报道,钙通道阻滞剂对血管收缩有益。[5]前列腺素E1,又称前列地尔,已被用于治疗外周循环功能不全,因为它能诱导血管舒张和血管生成,抑制血小板聚集、白细胞粘附和炎症。[6,7]在目前的研究中,前列地尔是第一个用于治疗CHLE患者手指溃疡的药物。将前列地尔(30 μg)溶于0.9%生理盐水(500 mL)中,静脉滴注2 h,每日2次,连用10 d。2周内疼痛和溃疡明显改善。激光多普勒血流测量显示,在8周的随访期间,手指微血管灌注增加。很少有研究讨论CHLE,本病例报告强调了前列地尔治疗CHLE的疗效。将进行进一步调查和长期随访。患者同意声明作者证明他们已经获得了所有适当的患者同意表格。在此表格中,患者已同意她的图像和其他临床信息将在杂志上报道。患者明白姓名和首字母不会被公布,并将尽力隐藏身份,但不能保证匿名。
{"title":"Efficacy of alprostadil in chilblain lupus erythematosus","authors":"Wei-En Wang, Chung-Hsing Chang","doi":"10.4103/ds.ds-d-23-00065","DOIUrl":"https://doi.org/10.4103/ds.ds-d-23-00065","url":null,"abstract":"Dear Editor, A 56-year-old woman presented with chronic pain in her digits. She had worked in the seafood frozen-packaging line of a food factory for many years. Physical examination revealed ulcerations on the pulps and knuckles of her digits, with hyperkeratosis and fissures [Figure 1a-d]. No similar lesions on toes were found. The lesions were worsened by exposure to a cold environment. Raynaud’s phenomenon and sclerodactyly were not observed. In addition, a patch of cicatricial alopecia was observed on the vertex of the scalp [Figure 1e]. Discoid lupus erythematosus was confirmed by skin biopsy.Figure 1: (a-d) Erythematous plaques with fissures and ulceration on the fingers and pulps of the digits. (e) A patch of cicatricial alopecia on the vertex of the scalp. (f and g) Bilateral hand magnetic resonance angiography showed patent distal radial arteries, ulnar to interdigital arteries, and postcontrast enhancement of soft tissue swelling over the 1st to 5th digits.Blood tests revealed high titers of anti-Ro/SSA antibodies (50.1 EliA U/mL) and low C4 levels (18.2 mg/dL). However, she tested negative for antinuclear antibodies (ANA), anticardiolipin antibodies, anti-Scl-70 antibodies, and anti-double-stranded DNA antibodies. The cryoglobulin and cold agglutinin tests were negative. A diagnosis of systemic lupus erythematosus (SLE) was not fulfilled. Bilateral hand magnetic resonance angiography showed patent distal radial arteries, ulnar to interdigital arteries, and postcontrast enhancement of soft-tissue swelling over the 1st to 5th digits [Figure 1f and g]. Based on her clinical symptoms and laboratory results, she was diagnosed with chilblain lupus erythematosus (CHLE). The proposed CHLE diagnostic criteria have not yet been validated, although the Mayo Clinic diagnostic criteria proposed by Su et al. include clinical presentation, laboratory findings, and histopathology.[1] She was treated with oral pentoxifylline and nifedipine for 5 months; however, only mild improvement was seen. We further administrated a 10-day regimen of intravenous alprostadil at a dose of 60 µg/day. Significant improvement in the digital ulcers was observed within 2 weeks [Figure 2a]. Laser Doppler flowmetry revealed increased microvascular perfusion in the digits of the left hand at 30°C and 44°C during the 8-week follow-up [Figure 2b].Figure 2: (a) The digital ulcers showed significant improvement within 2 weeks (left hand). (b) Laser Doppler flowmetry revealed an increase in microvascular perfusion in the middle digit of the left hand both at 30°C and 44°C after alprostadil treatment during an 8-week follow-up.CHLE is a rare form of cutaneous lupus erythematosus; based on previous studies, it coexists with SLE in 33%–88% of patients.[2,3] Moreover, SLE developed in these patients before or after the onset of CHLE.[2,3] CHLE lesions initially present as violaceous-erythematous papules and plaques on the toes, fingers, or face, and they worsen during exposure to co","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135136490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of cutaneous nocardiosis successfully treated with third-generation cephalosporin 第三代头孢菌素成功治疗皮肤诺卡菌病1例
4区 医学 Q3 Medicine Pub Date : 2023-11-03 DOI: 10.4103/ds.ds-d-23-00109
Tzu-Yu Liu, Feng-Ling Lin
Dear Editor, Cutaneous nocardiosis is a type of skin and soft-tissue infection caused by Nocardia species, a kind of bacteria isolated from the environment. Sulfamethoxazole is the priority choice of oral medication,[1] but impaired renal function is a concern. Herein, we present a case successfully treated with oral cefixime as an alternative. An 87-year-old man with diabetes mellitus, congestive heart failure, and stage 4 chronic kidney disease (estimated glomerular filtration rate: 28.5 mL/min/1.73 m²) suffered from painful lesions on the face after falling to the ground. Abrasion wound and ecchymosis developed initially, so he was brought to local clinic for management. The patient did not receive systemic immunosuppressant or glucocorticoids, nor was he diagnosed with malignancy or an autoimmune disease. Topical antibiotic was given, and his wound gradually healed. However, pustular eruptions at the trauma site developed 1 week later. Cellulitis was impressed first, so topical fusidic acid cream and oral doxycycline were applied after obtaining the wound culture. The primary wound culture yielded coagulase-negative Staphylococcus epidermidis, which indicated colonization or contamination of the specimen. His symptoms also did not improve after 1-week oral antibiotic treatment. He then came to the dermatology clinic. Physical examination revealed erythematous firm nodules and pustules with erythematous-based patches on the left cheek [Figure 1a]. The patient was afebrile then.Figure 1: Clinical presentation: (a) before treatment: erythematous nodules and pustules on left cheek; (b) after treatment: erythema and pustules on left cheek resolved.Differential diagnoses included bacterial cellulitis, atypical infection (e.g. sporotrichosis, nocardiosis, tuberculosis, nontuberculous mycobacterium, or leishmaniasis), or Majocchi granuloma. He then received skin biopsy with tissue culture. Pathology report revealed suppurative microabscesses with aggregation of histiocytes [Figure 2a]. Immunohistochemistry stain showed negative for Gram’s stain [Figure 2b], periodic acid–Schiff stain [Figure 2c], or acid-fast stain [Figure 2d]. The tissue culture yielded Nocardiabrasiliensis, so cutaneous nocardiosis was diagnosed. The chest X-ray only showed enlarged heart size without increased infiltration or nodule at the lung field. Considering the impaired renal function of the patient, sulfamethoxazole was not given. We prescribed alternative treatment with oral cefixime 100 mg twice a day. After 4-week treatment, the skin lesion of the patient almost resolved [Figure 1b].Figure 2: Histopathological investigation: (a) Histopathology stain of the skin biopsy revealed suppurative microabscesses with aggregation of histiocytes (H and E, ×200); immunohistochemical stain of skin biopsy revealed negative for (b) Gram’s stain (×200), (c) periodic acid–Schiff stain (×200), and (d) acid-fast stain (×200).Cutaneous nocardiosis is skin and soft-tissue infection from a ki
皮肤诺卡菌病是一种由诺卡菌引起的皮肤和软组织感染,诺卡菌是一种从环境中分离出来的细菌。磺胺甲恶唑是口服药物的首选[1],但肾功能受损是一个问题。在这里,我们提出了一个案例成功地治疗口服头孢克肟作为一种选择。一名87岁男性,患有糖尿病、充血性心力衰竭和4期慢性肾脏疾病(估计肾小球滤过率:28.5 mL/min/1.73 m²),跌倒后面部出现疼痛病变。最初出现擦伤和瘀斑,因此被带到当地诊所治疗。患者未接受全身免疫抑制剂或糖皮质激素治疗,也未被诊断为恶性肿瘤或自身免疫性疾病。局部给予抗生素治疗,伤口逐渐愈合。然而,创伤部位1周后出现脓疱。首先是蜂窝织炎,因此在获得伤口培养后,局部应用夫西地酸乳膏和口服强力霉素。最初的伤口培养产生凝固酶阴性表皮葡萄球菌,这表明定植或污染标本。口服抗生素治疗1周后症状未见改善。然后他来到了皮肤科诊所。体格检查显示左脸颊有红斑性硬结节和脓疱,伴有红斑性斑块[图1a]。病人当时不发烧。图1:临床表现:(a)治疗前:左脸颊红斑性结节、脓疱;(b)治疗后:左脸颊红斑、脓疱消退。鉴别诊断包括细菌性蜂窝织炎、非典型感染(如孢子虫病、诺卡病、结核病、非结核分枝杆菌或利什曼病)或马氏肉芽肿。然后接受皮肤活检和组织培养。病理报告显示化脓性微脓肿伴组织细胞聚集[图2a]。免疫组化染色革兰氏染色阴性[图2b],周期性酸-希夫染色阴性[图2c],抗酸染色阴性[图2d]。组织培养产生诺卡菌,诊断为皮肤诺卡菌病。胸部x线片仅显示心脏增大,未见肺野浸润或结节增加。考虑到患者肾功能受损,未给予磺胺甲恶唑治疗。我们开了另一种治疗方法,口服头孢克肟100毫克,每天两次。治疗4周后,患者皮肤病变基本消退[图1b]。图2:组织病理学检查:(a)皮肤活检组织病理学染色显示化脓性微脓肿,组织细胞聚集(H和E, ×200);皮肤活检免疫组化染色(b)革兰氏染色(×200), (c)周期性酸-希夫染色(×200)和(d)抗酸染色(×200)为阴性。皮肤诺卡菌病是由一种需氧革兰氏阳性丝状细菌引起的皮肤和软组织感染。进入途径包括由于创伤和免疫功能低下宿主的血液直接接种。皮肤表现可表现为结节性脓疱病变,伴或不伴孢子毛样分布,蜂窝织炎或溃疡性病变。[2]最常见的皮外病变是肺诺卡菌病,尤其是免疫抑制患者。一线治疗是磺胺类药物,如磺胺甲恶唑加或不加甲氧苄啶。其他替代品包括米诺环素、阿米卡星、亚胺培南、替加环素和第三代头孢菌素。[3]严重或复杂病例建议联合治疗。对于免疫抑制状态的患者,强烈建议延长抗生素使用1-4个月。当给予适当的抗生素治疗时,原发性皮肤诺卡菌病的预后良好。回到我们的病人,由于肾功能受损,我们排除了磺胺甲恶唑和阿米卡星的治疗选择。米诺环素不可行,因为先前对强力霉素缺乏反应。患者拒绝住院治疗,无法给予亚胺培南、替加环素治疗。因此,口服形式的第三代头孢菌素可能是一个适当的选择,基于先前的文章综述和患者的临床表现的反应。总之,皮肤诺卡菌病可能源于与植物和土壤有关的局部创伤,导致脓肿、蜂窝织炎或孢子毛样淋巴性皮肤结节。磺胺甲恶唑是一线治疗,但第三代头孢菌素可能是不能耐受磺胺类药物的患者的有效选择。患者同意声明作者证明他们已经获得了所有适当的患者同意表格。在这张表格中,患者已经同意他的图像和其他临床信息将在杂志上报道。 患者明白,他的姓名和首字母不会被公布,并将尽力隐藏他的身份,但不能保证匿名。数据可用性声明数据共享不适用于本文,因为在当前研究中没有生成或分析数据集。财政支持及赞助无。利益冲突没有利益冲突。
{"title":"A case of cutaneous nocardiosis successfully treated with third-generation cephalosporin","authors":"Tzu-Yu Liu, Feng-Ling Lin","doi":"10.4103/ds.ds-d-23-00109","DOIUrl":"https://doi.org/10.4103/ds.ds-d-23-00109","url":null,"abstract":"Dear Editor, Cutaneous nocardiosis is a type of skin and soft-tissue infection caused by Nocardia species, a kind of bacteria isolated from the environment. Sulfamethoxazole is the priority choice of oral medication,[1] but impaired renal function is a concern. Herein, we present a case successfully treated with oral cefixime as an alternative. An 87-year-old man with diabetes mellitus, congestive heart failure, and stage 4 chronic kidney disease (estimated glomerular filtration rate: 28.5 mL/min/1.73 m²) suffered from painful lesions on the face after falling to the ground. Abrasion wound and ecchymosis developed initially, so he was brought to local clinic for management. The patient did not receive systemic immunosuppressant or glucocorticoids, nor was he diagnosed with malignancy or an autoimmune disease. Topical antibiotic was given, and his wound gradually healed. However, pustular eruptions at the trauma site developed 1 week later. Cellulitis was impressed first, so topical fusidic acid cream and oral doxycycline were applied after obtaining the wound culture. The primary wound culture yielded coagulase-negative Staphylococcus epidermidis, which indicated colonization or contamination of the specimen. His symptoms also did not improve after 1-week oral antibiotic treatment. He then came to the dermatology clinic. Physical examination revealed erythematous firm nodules and pustules with erythematous-based patches on the left cheek [Figure 1a]. The patient was afebrile then.Figure 1: Clinical presentation: (a) before treatment: erythematous nodules and pustules on left cheek; (b) after treatment: erythema and pustules on left cheek resolved.Differential diagnoses included bacterial cellulitis, atypical infection (e.g. sporotrichosis, nocardiosis, tuberculosis, nontuberculous mycobacterium, or leishmaniasis), or Majocchi granuloma. He then received skin biopsy with tissue culture. Pathology report revealed suppurative microabscesses with aggregation of histiocytes [Figure 2a]. Immunohistochemistry stain showed negative for Gram’s stain [Figure 2b], periodic acid–Schiff stain [Figure 2c], or acid-fast stain [Figure 2d]. The tissue culture yielded Nocardiabrasiliensis, so cutaneous nocardiosis was diagnosed. The chest X-ray only showed enlarged heart size without increased infiltration or nodule at the lung field. Considering the impaired renal function of the patient, sulfamethoxazole was not given. We prescribed alternative treatment with oral cefixime 100 mg twice a day. After 4-week treatment, the skin lesion of the patient almost resolved [Figure 1b].Figure 2: Histopathological investigation: (a) Histopathology stain of the skin biopsy revealed suppurative microabscesses with aggregation of histiocytes (H and E, ×200); immunohistochemical stain of skin biopsy revealed negative for (b) Gram’s stain (×200), (c) periodic acid–Schiff stain (×200), and (d) acid-fast stain (×200).Cutaneous nocardiosis is skin and soft-tissue infection from a ki","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135869199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous mucinosis of infancy: A case report 婴儿皮肤黏液病1例报告
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.4103/ds.ds-d-23-00018
Q. Luo, Guoying Wang, Qin He, Xiangang Fang
{"title":"Cutaneous mucinosis of infancy: A case report","authors":"Q. Luo, Guoying Wang, Qin He, Xiangang Fang","doi":"10.4103/ds.ds-d-23-00018","DOIUrl":"https://doi.org/10.4103/ds.ds-d-23-00018","url":null,"abstract":"","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91306607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dupilumab for patients with photoaggravated dermatoses with skin nodules as main manifestations: A case series 杜匹单抗用于以皮肤结节为主要表现的光加重性皮肤病患者:一个病例系列
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.4103/ds.ds-d-22-00172
Rui-Xian Ye, X. Tian, Jingyao Liang, Rujun Xue, Qiongxiao Huang, Yimin Liang, YuMei Liu
Photoaggravated dermatoses (PD) are diseases that occur without ultraviolet (UV) radiation but are sometimes or frequently exacerbated by UV radiation. The clinical manifestations of PD are varied, some patients may present with pruritic nodular lesions at the site of light exposure, which possibly through a light-induced type 2 inflammatory response. Some cases may be difficult to treat, safe and effective treatment methods are constantly being explored. Here, we reported five patients with moderate to severe PD with skin nodules as main manifestations successfully treated with dupilumab, who were previously resistant to conventional treatment. After the 16-week treatment period, dupilumab showed good efficacy and safety in PD mainly characterized by nodules.
光加重性皮肤病(PD)是一种在没有紫外线照射的情况下发生的疾病,但有时或经常因紫外线照射而加重。PD的临床表现多种多样,部分患者可能在光照部位出现瘙痒性结节状病变,这可能是光诱导的2型炎症反应。有些病例可能难以治疗,人们正在不断探索安全有效的治疗方法。在这里,我们报告了5例以皮肤结节为主要表现的中重度PD患者,他们以前对常规治疗有耐药性,但杜匹单抗治疗成功。经过16周的治疗期,dupilumab在以结节为主的PD中显示出良好的疗效和安全性。
{"title":"Dupilumab for patients with photoaggravated dermatoses with skin nodules as main manifestations: A case series","authors":"Rui-Xian Ye, X. Tian, Jingyao Liang, Rujun Xue, Qiongxiao Huang, Yimin Liang, YuMei Liu","doi":"10.4103/ds.ds-d-22-00172","DOIUrl":"https://doi.org/10.4103/ds.ds-d-22-00172","url":null,"abstract":"Photoaggravated dermatoses (PD) are diseases that occur without ultraviolet (UV) radiation but are sometimes or frequently exacerbated by UV radiation. The clinical manifestations of PD are varied, some patients may present with pruritic nodular lesions at the site of light exposure, which possibly through a light-induced type 2 inflammatory response. Some cases may be difficult to treat, safe and effective treatment methods are constantly being explored. Here, we reported five patients with moderate to severe PD with skin nodules as main manifestations successfully treated with dupilumab, who were previously resistant to conventional treatment. After the 16-week treatment period, dupilumab showed good efficacy and safety in PD mainly characterized by nodules.","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76087574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Paraneoplastic bullous pemphigoid presented with figurate erythema: A case report and review of literature 副肿瘤大疱性类天疱疮伴象状红斑1例并文献复习
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-07-01 DOI: 10.4103/ds.ds-d-22-00210
Yu-Hua Lee, Nai-Wen Kang, P. Cheng
{"title":"Paraneoplastic bullous pemphigoid presented with figurate erythema: A case report and review of literature","authors":"Yu-Hua Lee, Nai-Wen Kang, P. Cheng","doi":"10.4103/ds.ds-d-22-00210","DOIUrl":"https://doi.org/10.4103/ds.ds-d-22-00210","url":null,"abstract":"","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85998076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Scoring systems for pemphigus 天疱疮的评分系统
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.4103//DS.V41-1_Editorial
C. Hsu
{"title":"Scoring systems for pemphigus","authors":"C. Hsu","doi":"10.4103//DS.V41-1_Editorial","DOIUrl":"https://doi.org/10.4103//DS.V41-1_Editorial","url":null,"abstract":"","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79983013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients 富血小板血浆治疗斑秃:17例患者的回顾性评价
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.4103/ds.ds-d-22-00205
Yusuf Kelleci, F. Aydın, Gokhan Sahin, E. Yuksel
Background: Alopecia areata (AA) is a disease of unknown etiology which is thought to be autoimmune, that presents challenges in terms of treatment. Platelet-rich plasma (PRP) can induce the development of new hair follicles through various growth factors it contains. PRP could be a treatment option for patients with AA. Objectives: We aim to evaluate the effectiveness and safety of PRP treatment in patients with patch-type AA. Methods: The study included 17 patients diagnosed with patch-type AA who received PRP treatment at least 3 sessions every 4 weeks. Treatment response was evaluated by calculating the severity of alopecia tool (SALT) scores. Results: The mean age of patients was 29.70 ± 10.09, and the mean disease duration was 18.17 ± 39.46 months. The mean SALT score of 17 patients was 6.82 ± 4.96 and 4.35 ± 4.58 before treatment and at the end of the 3rd month, respectively. The reduction in SALT scores was statistically significant (P = 0.01). At the end of the 3rd month, six patients (35.3%) had an excellent response, one patient (5.9%) had a good response, one patient (5.9%) had a partial response, and nine patients (52.9%) showed no response. The mean SALT scores of four patients who received six sessions of PRP of treatment were 6.00 ± 2.94 and 1.75 ± 2.06 at the end of the 6th month. No serious side effects were noted. Relapse was observed in one patient within 1 year of follow-up. Conclusion: As a result of our study, PRP treatment was found to be an effective and reliable treatment method in patients with mild AA.
背景:斑秃(AA)是一种病因不明的疾病,被认为是自身免疫性疾病,在治疗方面提出了挑战。富血小板血浆(PRP)可以通过其所含的多种生长因子诱导新毛囊的发育。PRP可能是AA患者的一种治疗选择。目的:评价PRP治疗贴片型AA的有效性和安全性。方法:研究纳入17例诊断为贴片型AA的患者,每4周至少接受3次PRP治疗。通过计算脱发工具(SALT)评分来评估治疗效果。结果:患者平均年龄29.70±10.09岁,平均病程18.17±39.46个月。17例患者治疗前和治疗3月末的平均SALT评分分别为6.82±4.96和4.35±4.58。SALT评分降低有统计学意义(P = 0.01)。第3个月末,极缓解6例(35.3%),良好缓解1例(5.9%),部分缓解1例(5.9%),无缓解9例(52.9%)。接受6次PRP治疗的4例患者6月末SALT平均评分分别为6.00±2.94和1.75±2.06。没有发现严重的副作用。1例患者随访1年内复发。结论:本研究发现PRP治疗是治疗轻度AA患者有效可靠的方法。
{"title":"Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients","authors":"Yusuf Kelleci, F. Aydın, Gokhan Sahin, E. Yuksel","doi":"10.4103/ds.ds-d-22-00205","DOIUrl":"https://doi.org/10.4103/ds.ds-d-22-00205","url":null,"abstract":"Background: Alopecia areata (AA) is a disease of unknown etiology which is thought to be autoimmune, that presents challenges in terms of treatment. Platelet-rich plasma (PRP) can induce the development of new hair follicles through various growth factors it contains. PRP could be a treatment option for patients with AA. Objectives: We aim to evaluate the effectiveness and safety of PRP treatment in patients with patch-type AA. Methods: The study included 17 patients diagnosed with patch-type AA who received PRP treatment at least 3 sessions every 4 weeks. Treatment response was evaluated by calculating the severity of alopecia tool (SALT) scores. Results: The mean age of patients was 29.70 ± 10.09, and the mean disease duration was 18.17 ± 39.46 months. The mean SALT score of 17 patients was 6.82 ± 4.96 and 4.35 ± 4.58 before treatment and at the end of the 3rd month, respectively. The reduction in SALT scores was statistically significant (P = 0.01). At the end of the 3rd month, six patients (35.3%) had an excellent response, one patient (5.9%) had a good response, one patient (5.9%) had a partial response, and nine patients (52.9%) showed no response. The mean SALT scores of four patients who received six sessions of PRP of treatment were 6.00 ± 2.94 and 1.75 ± 2.06 at the end of the 6th month. No serious side effects were noted. Relapse was observed in one patient within 1 year of follow-up. Conclusion: As a result of our study, PRP treatment was found to be an effective and reliable treatment method in patients with mild AA.","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77850899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Expression of acyl-CoA synthetase medium-chain 3 is associated with obesity in melanoma patients and correlates with androgen receptor 酰基辅酶a合成酶中链3的表达与黑色素瘤患者肥胖相关,并与雄激素受体相关
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.4103/ds.ds-d-22-00141
Yuan Zheng, Pingdong Jiang, Liyin Zhang
Background: Malignant melanoma is a typical type of cancer that feature the obesity paradox. Objectives: We aim to evaluate the role of acyl-CoA synthetase medium-chain 3 (ACSM3) in obesity paradox in malignant melanoma (MM). Methods: With reproduction of the Cancer Genome Atlas (TCGA) MM dataset and validation using immunohistochemistry, we evaluated correlations of ACSM3 expression with body mass index (BMI), gender, and androgen receptor (AR) expression. Results: ACSM family genes were downregulated in MM and in normal skin exposed to ultraviolet. Higher expression of ACSM3 was associated with improved overall survival in men but not in women. Subgroup analysis showed the best survival outcome in obese patients with high ACSM3 expression. ACSM3 expression was significantly lower in cases with ulceration. NET-GE-based gene enrichment analysis of ACSM-overexpressed cases showed significant enrichment in lipid metabolism and butanoate metabolism. AR stood as the top possible transcription factor of ACSM3 using multiple algorithms. Expressions of ACSM3 and AR were positively correlated in obese men and overweight women. ACSM3 expression was positively correlated with BMI in men and overweight women. Conclusion: ACSM3 expression is associated with obesity in MM patients and correlates with AR. Functional analysis linking the findings to the obesity paradox warrants further study.
背景:恶性黑色素瘤是一种典型的以肥胖悖论为特征的癌症。目的:探讨酰基辅酶a合成酶中链3 (ACSM3)在恶性黑色素瘤(MM)肥胖悖论中的作用。方法:通过复制癌症基因组图谱(TCGA) MM数据集并使用免疫组织化学进行验证,我们评估了ACSM3表达与体重指数(BMI)、性别和雄激素受体(AR)表达的相关性。结果:ACSM家族基因在MM和正常皮肤暴露于紫外线下均下调。在男性中,ACSM3的高表达与总生存率的提高有关,而在女性中则无关。亚组分析显示,ACSM3高表达的肥胖患者生存率最高。溃疡组ACSM3表达明显降低。基于net - ge的基因富集分析显示,acsm过表达病例的脂质代谢和丁酸盐代谢显著富集。在多种算法下,AR被认为是ACSM3最可能的转录因子。在肥胖男性和超重女性中,ACSM3和AR的表达呈正相关。在男性和超重女性中,ACSM3的表达与BMI呈正相关。结论:ACSM3的表达与MM患者的肥胖相关,并与AR相关。将该发现与肥胖悖论联系起来的功能分析值得进一步研究。
{"title":"Expression of acyl-CoA synthetase medium-chain 3 is associated with obesity in melanoma patients and correlates with androgen receptor","authors":"Yuan Zheng, Pingdong Jiang, Liyin Zhang","doi":"10.4103/ds.ds-d-22-00141","DOIUrl":"https://doi.org/10.4103/ds.ds-d-22-00141","url":null,"abstract":"Background: Malignant melanoma is a typical type of cancer that feature the obesity paradox. Objectives: We aim to evaluate the role of acyl-CoA synthetase medium-chain 3 (ACSM3) in obesity paradox in malignant melanoma (MM). Methods: With reproduction of the Cancer Genome Atlas (TCGA) MM dataset and validation using immunohistochemistry, we evaluated correlations of ACSM3 expression with body mass index (BMI), gender, and androgen receptor (AR) expression. Results: ACSM family genes were downregulated in MM and in normal skin exposed to ultraviolet. Higher expression of ACSM3 was associated with improved overall survival in men but not in women. Subgroup analysis showed the best survival outcome in obese patients with high ACSM3 expression. ACSM3 expression was significantly lower in cases with ulceration. NET-GE-based gene enrichment analysis of ACSM-overexpressed cases showed significant enrichment in lipid metabolism and butanoate metabolism. AR stood as the top possible transcription factor of ACSM3 using multiple algorithms. Expressions of ACSM3 and AR were positively correlated in obese men and overweight women. ACSM3 expression was positively correlated with BMI in men and overweight women. Conclusion: ACSM3 expression is associated with obesity in MM patients and correlates with AR. Functional analysis linking the findings to the obesity paradox warrants further study.","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76551356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant perforating pilomatricoma: A case report 巨大穿孔性毛囊基质瘤1例
IF 2.5 4区 医学 Q3 Medicine Pub Date : 2023-04-01 DOI: 10.4103/ds.ds-d-23-00001
W. Nho, Junyoung Kim, S. Kee, Dong-Jin Kim, K. Yoon
{"title":"Giant perforating pilomatricoma: A case report","authors":"W. Nho, Junyoung Kim, S. Kee, Dong-Jin Kim, K. Yoon","doi":"10.4103/ds.ds-d-23-00001","DOIUrl":"https://doi.org/10.4103/ds.ds-d-23-00001","url":null,"abstract":"","PeriodicalId":11107,"journal":{"name":"Dermatologica Sinica","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73605088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dermatologica Sinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1